Page last updated: 2024-11-02

palmidrol and Bladder Diseases

palmidrol has been researched along with Bladder Diseases in 1 studies

palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.

Research Excerpts

ExcerptRelevanceReference
"Referred hyperalgesia to a somatopically appropriate superficial site is a cardinal symptom of visceral inflammatory pain and has been demonstrated after turpentine-induced urinary bladder inflammation in the rat."1.31Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder. ( Farquhar-Smith, WP; Rice, AS, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farquhar-Smith, WP1
Rice, AS1

Other Studies

1 other study available for palmidrol and Bladder Diseases

ArticleYear
Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder.
    Anesthesiology, 2001, Volume: 94, Issue:3

    Topics: Adjuvants, Immunologic; Amides; Analgesics; Animals; Arachidonic Acids; Area Under Curve; Cannabinoi

2001